Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Digoxin	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Fall	B-Falls
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
DM2,	O
___,	O
CKD,	O
AFib	O
on	O
coumadin	O
here	O
after	O
mechanical	O
fall	B-Falls
down	O
10	O
stairs	O
landing	O
on	O
right	O
side.	O
She	O
did	O
hit	O
her	O
head	O
but	O
no	O
LOC.	O
She	O
was	O
walking	O
with	O
her	O
walker	B-Mobile_with_aid
at	O
the	O
top	O
of	O
the	O
stairs	O
with	O
her	O
neice.	O
When	O
her	O
neice	O
turned,	O
she	O
took	O
a	O
bad	O
step	O
and	O
fell	B-Falls
down	O
the	O
stairs.	O
The	O
patient	O
herself	O
cannot	O
give	O
a	O
clear	O
history	O
of	O
the	O
events	O
leading	O
to	O
the	O
fall	B-Falls
and	O
suggests	O
that	O
she	O
may	O
have	O
felt	O
a	O
little	O
dizzy.	O
In	O
the	O
ED,	O
she	O
was	O
hemodynamically	O
stable	O
and	O
endorsed	O
significant	O
MSK	O
pain	O
in	O
multiple	O
sites.	O
her	O
INR	O
was	O
found	O
to	O
be	O
5.0.	O
Given	O
the	O
high-risk	O
situation	O
she	O
had	O
a	O
CT	O
torso	O
with	O
contrast.	O
CT	O
head	O
negative,	O
CT	O
C-spine	O
without	O
acute	O
fracture	O
or	O
traumatic	O
malalignment.	O
CT	O
chest/abd/pelvis	O
notable	O
for	O
a	O
growing	O
breast	O
mass,	O
a	O
T2	O
spinous	O
process	O
fracture	O
and	O
a	O
possible	O
R	O
posterior	O
rib	O
fracture,	O
as	O
well	O
as	O
a	O
large	O
distended	O
bladder	O
with	O
hydroureter	O
and	O
hydronephrosis.	O
Trauma	O
surgery	O
consulted	O
and	O
felt	O
no	O
operative	O
intervention.	O
Other	O
labs	O
notable	O
for	O
stable	O
H&H	O
and	O
___	O
with	O
Cr	O
2.3	O
from	O
baseline	O
1.4.	O
UA	O
was	O
bland.	O
She	O
was	O
given	O
1L	O
hydration	O
with	O
contrast.	O
She	O
also	O
desatted	O
to	O
89%	O
on	O
RA	O
and	O
was	O
placed	O
on	O
oxygen.	O
In	O
the	O
weeks	O
leading	O
up	O
to	O
this,	O
she	O
reports	O
being	O
in	O
her	O
usual	O
state	O
of	O
health.	O
She	O
reports	O
one	O
day	O
of	O
nausea	O
+	O
emesis	O
x1	O
several	O
days	O
ago,	O
and	O
one	O
day	O
of	O
diarrhea	O
also	O
several	O
days	O
ago.	O
No	O
fevers.	O
No	O
new	O
med	O
changes	O
or	O
recent	O
antibiotics.	O
Unclear	O
how	O
her	O
PO	O
intake	O
has	O
been,	O
the	O
nurse	O
from	O
her	O
nursing	O
home	O
denied	O
any	O
changes	O
to	O
her	O
PO	O
intake.	O
She	O
also	O
suggests	O
that	O
she	O
has	O
been	O
urinating	O
her	O
normal	O
amount.	O
Denies	O
any	O
difficulty	O
urinating.	O
She	O
is	O
not	O
complaining	O
of	O
pain	O
in	O
any	O
particular	O
location.	O
Past	O
Medical	O
History:	O
PAST	O
MEDICAL	O
HISTORY:	O
-	O
diabetes	O
mellitus	O
type	O
II	O
-	O
h/o	O
rectal	O
cancer,	O
s/p	O
rectal	O
XRT,	O
and	O
resection	O
___	O
-	O
atrial	O
fibrillation	O
-	O
Glaucoma	O
-	O
moderate	O
pulmonary	O
artery	O
systolic	O
hypertension	O
-	O
Diastolic	O
CHF	O
-	O
EF	O
(50%)	O
-	O
transanal	O
endoscopic	O
microsurgical	O
excision	O
for	O
rectum	O
CA	O
hysterectomy	O
-	O
diabetic	O
renal	O
insuff	O
-	O
osteopenia	O
-	O
___	O
rectal	B-Lower_gastrointestinal_haemorrhage
bleeding	B-Lower_gastrointestinal_haemorrhage
-	O
radiation	O
proctitis.HCT	O
18.	O
.	O
PAST	O
SURGICAL	O
HISTORY:	O
-	O
incomplete	O
transanal	O
excsion	O
of	O
rectal	O
carcinoma	O
(OSH)	O
-	O
___	O
-	O
transanal	O
endoscopic	O
microsurgical	O
excision	O
of	O
left	O
lateral	O
polypoid	O
lesion	O
encompassing	O
50%	O
of	O
the	O
rectal	O
wall.	O
Social	O
History:	O
___	O
Family	O
History:	O
Her	O
sister	O
had	O
breast	O
cancer.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
VS	O
-	O
98.5	O
65	O
168/59	O
100%	O
2L	O
General:	O
Appears	O
well,	O
NAD.	O
AOX2.5	B-Delirium
(year	O
was	O
___.	O
HEENT:	O
Head	O
atruamtic,	O
ecchymosis	O
on	O
forehead,	O
laceration	O
on	O
chin.	O
Neck:	O
No	O
tenderness	O
to	O
palpation	O
of	O
full	O
length	O
of	O
spine.	O
CV:	O
RRR.	O
Systolic	O
murmur	O
at	O
___.	O
Systolic	O
murmur	O
of	O
different	O
character	O
at	O
RLSB.	O
Lungs:	O
Crackles	O
at	O
R	O
base.	O
Abdomen:	O
Soft,	O
NT,	O
ND.	O
Ext:	O
Trace	O
pitting	O
edema	O
in	O
L	O
leg.	O
Ecchymoses	O
and	O
small	O
hematomas	O
over	O
bilateral	O
shins.	O
Full	O
ROM	O
of	O
both	O
hips	O
and	O
legs.	O
Pelvis	O
stable.	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
VS	O
Tmax	O
98.2	O
Tc	O
97.9	O
HR	O
54-66	O
BP	O
135/80-167/70	O
RR	O
___	O
SpO2	O
94-99%	O
RA,	O
I/O	O
___,	O
8h:	O
NR/200	O
General:	O
Appears	O
well,	O
NAD.	O
AOx3	B-Delirium
HEENT:	O
Ecchymosis	O
on	O
forehead,	O
laceration	O
on	O
chin.	O
Neck:	O
No	O
tenderness	O
to	O
palpation	O
of	O
full	O
length	O
of	O
spine.	O
CV:	O
RRR.	O
Systolic	O
murmur	O
at	O
___.	O
Systolic	O
murmur	O
of	O
different	O
character	O
at	O
RLSB.	O
Lungs:	O
Crackles	O
to	O
___	O
way	O
up	O
both	O
lungs	O
(R>L).	O
Abdomen:	O
Soft,	O
NT,	O
more	O
distended	O
and	O
tympanic	O
compared	O
to	O
yesterday.	O
+Normoactive	O
BS.	O
Ext:	O
Trace	O
pitting	O
edema	O
in	O
L	O
leg.	O
Ecchymoses	O
and	O
small	O
hematomas	O
over	O
bilateral	O
shins	O
with	O
overlying	O
erythema	O
on	O
LLE	O
with	O
interval	O
progression.	O
Full	O
ROM	O
of	O
both	O
hips	O
and	O
legs.	O
Pelvis	O
stable.	O
Neuro:	O
Grossly	O
normal	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
___	O
08:41PM	O
%HbA1c-7.0*	O
eAG-154*	O
___	O
03:20PM	O
URINE	O
HOURS-RANDOM	O
___	O
03:20PM	O
URINE	O
UHOLD-HOLD	O
___	O
03:20PM	O
URINE	O
COLOR-Straw	O
APPEAR-Clear	O
SP	O
___	O
___	O
03:20PM	O
URINE	O
BLOOD-SM	O
NITRITE-NEG	O
PROTEIN-NEG	O
GLUCOSE-NEG	O
KETONE-NEG	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-6.0	O
LEUK-NEG	O
___	O
03:20PM	O
URINE	O
RBC-<1	O
WBC-0	O
BACTERIA-NONE	O
YEAST-NONE	O
EPI-0	O
___	O
03:20PM	O
URINE	O
MUCOUS-RARE	O
___	O
03:17PM	O
COMMENTS-GREEN	O
TOP	O
___	O
03:17PM	O
K+-5.2*	O
___	O
01:50PM	O
GLUCOSE-139*	O
UREA	O
N-65*	O
CREAT-2.3*	O
SODIUM-140	O
POTASSIUM-5.2*	O
CHLORIDE-106	O
TOTAL	O
CO2-21*	O
ANION	O
GAP-18	O
___	O
01:50PM	O
estGFR-Using	O
this	O
___	O
01:50PM	O
ALT(SGPT)-18	O
AST(SGOT)-22	O
CK(CPK)-74	O
ALK	O
PHOS-138*	O
TOT	O
BILI-0.4	O
___	O
01:50PM	O
cTropnT-0.02*	O
___	O
01:50PM	O
CK-MB-4	O
___	O
01:50PM	O
ALBUMIN-4.3	O
CALCIUM-9.7	O
PHOSPHATE-3.9	O
MAGNESIUM-2.2	O
___	O
01:50PM	O
DIGOXIN-1.1	O
___	O
01:50PM	O
WBC-8.4	O
RBC-3.72*	O
HGB-10.9*	O
HCT-34.1*	O
MCV-92	O
MCH-29.4	O
MCHC-32.1	O
RDW-15.9*	O
___	O
01:50PM	O
NEUTS-81.7*	O
LYMPHS-11.2*	O
MONOS-4.5	O
EOS-2.3	O
BASOS-0.3	O
___	O
01:50PM	O
PLT	O
COUNT-127*	O
___	O
01:50PM	O
___	O
PTT-51.0*	O
___	O
DISCHARGE	O
LABS:	O
IMAGING:	O
CT	O
Head:	O
No	O
acute	O
intracranial	B-Intracranial_haemorrhage
hemorrhage	B-Intracranial_haemorrhage
or	O
mass	O
effect	O
or	O
acute	O
fracture.	O
Right	O
posterior	O
scalp	O
hematoma.	O
CT	O
torso:	O
1.	O
Nodule	O
posterior	O
to	O
the	O
left	O
lobe	O
of	O
thyroid	O
likely	O
exophytic	O
thyroid	O
nodule.	O
Could	O
be	O
further	O
assessed	O
with	O
targeted	O
ultrasound	O
if	O
clinically	O
indicated.	O
2.	O
A	O
high-density,	O
presumably	O
enhancing	O
mass,	O
in	O
the	O
left	O
breast	O
measuring	O
1.6	O
x	O
1.4	O
cm	O
has	O
increased	O
in	O
size	O
since	O
___	O
at	O
which	O
time	O
it	O
measured	O
1.3	O
x	O
1.2	O
cm.	O
This	O
could	O
represent	O
a	O
neoplasm.	O
Suggest	O
clinical	O
assessment	O
and	O
consider	O
dedicated	O
further	O
imaging	O
if	O
clinically	O
indicated.	O
3.	O
Moderate	O
cardiomegaly.	O
4.	O
Small	O
right	O
non-hemorrhagic	O
pleural	O
effusion.	O
There	O
is	O
bibasilar	O
distal	O
atelectasis	O
was	O
mild	O
right	O
basal	O
patchy	O
infiltrate	O
also.	O
5.	O
In	O
the	O
neck	O
of	O
the	O
gallbladder	O
there	O
is	O
a	O
stone	O
measuring	O
1.7	O
cm.	O
6.	O
Trace	O
perihepatic	O
ascites.	O
7.	O
Markedly	O
distended	O
bladder.	O
There	O
is	O
mild	O
left	O
hydronephrosis	O
and	O
hydroureter.	O
Indeterminate	O
left	O
interpolar	O
and	O
upper	O
pole	O
lesions.	O
Suggest	O
renal	O
ultrasound	O
when	O
bladder	O
empty.	O
8.	O
Aherosclerotic	O
plaque	O
narrows	O
the	O
origin	O
of	O
the	O
superior	O
mesenteric	O
artery.	O
9.	O
T2	O
spinous	O
process	O
fracture.	O
(Discussed	O
by	O
Dr.	O
___	O
at	O
approximately	O
17:00	O
on	O
___	O
with	O
Dr.	O
___.	O
Possible	O
right	O
posterior	O
fifth	O
rib	O
fracture.	O
RENAL	O
ULTRASOUND:	O
1.	O
No	O
evidence	O
of	O
hydronephrosis	O
or	O
main	O
renal	O
vein	O
occlusion.	O
2.	O
2.0	O
cm	O
septated	O
cystic	O
lesion	O
within	O
the	O
lower	O
pole	O
of	O
left	O
kidney	O
containing	O
a	O
1.0	O
cm	O
peripheral	O
calcification.	O
MSK	O
IMAGING:	O
all	O
without	O
acute	O
findings,	O
unable	O
to	O
rule	O
out	O
non-displaced	O
fracture	O
given	O
degree	O
of	O
osteopenia.	O
___	O
DUP	O
EXTEXT	O
BIL	O
(MAP)	O
___	O
Impression:	O
Negative	O
for	O
DVT	O
bilaterally	O
MICROBIOLOGY:	O
Urine	O
Cx	O
___:	O
No	O
growth	O
___	O
1:06	O
pm	O
URINE	O
Source:	O
Catheter.	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
ESCHERICHIA	O
COLI.	O
>100,000	O
ORGANISMS/ML..	O
PRESUMPTIVE	O
IDENTIFICATION.	O
Cefazolin	O
interpretative	O
criteria	O
are	O
based	O
on	O
a	O
dosage	O
regimen	O
of	O
2g	O
every	O
8h.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
ESCHERICHIA	O
COLI	O
|	O
AMPICILLIN------------	O
<=2	O
S	O
AMPICILLIN/SULBACTAM--	O
<=2	O
S	O
CEFAZOLIN-------------	O
<=4	O
S	O
CEFEPIME--------------	O
<=1	O
S	O
CEFTAZIDIME-----------	O
<=1	O
S	O
CEFTRIAXONE-----------	O
<=1	O
S	O
CIPROFLOXACIN---------<=0.25	O
S	O
GENTAMICIN------------	O
<=1	O
S	O
MEROPENEM-------------<=0.25	O
S	O
NITROFURANTOIN--------	O
<=16	O
S	O
PIPERACILLIN/TAZO-----	O
<=4	O
S	O
TOBRAMYCIN------------	O
<=1	O
S	O
TRIMETHOPRIM/SULFA----	O
<=1	O
S	O
___	O
9:33	O
am	O
STOOL	O
CONSISTENCY:	O
NOT	O
APPLICABLE	O
Source:	O
Stool.	O
**FINAL	O
REPORT	O
___	O
C.	O
difficile	O
DNA	O
amplification	O
assay	O
(Final	O
___:	O
Negative	O
for	O
toxigenic	O
C.	O
difficile	O
by	O
the	O
Illumigene	O
DNA	O
amplification	O
assay.	O
(Reference	O
Range-Negative).	O
DISCHARGE	O
LABS:	O
___	O
07:45AM	O
BLOOD	O
WBC-6.2	O
RBC-3.14*	O
Hgb-9.1*	O
Hct-30.0*	O
MCV-96	O
MCH-28.8	O
MCHC-30.1*	O
RDW-17.1*	O
Plt	O
___	O
___	O
07:45AM	O
BLOOD	O
Plt	O
___	O
___	O
07:45AM	O
BLOOD	O
Glucose-128*	O
UreaN-44*	O
Creat-2.0*	O
Na-145	O
K-4.4	O
Cl-113*	O
HCO3-21*	O
AnGap-15	O
___	O
07:45AM	O
BLOOD	O
Calcium-9.2	O
Phos-3.0	O
Mg-2.___	O
y.o.	O
F	O
with	O
DM2,	O
CKD,	O
dCHF,	O
AFIb	O
on	O
coumadin	O
who	O
presents	O
after	O
a	O
fall	B-Falls
with	O
urinary	O
retention,	O
___,	O
accelerated	O
junctional	O
rhythm	O
and	O
hypoxia.	O
Thankfully,	O
escaped	O
significant	O
MSK	O
injuries	O
from	O
fall.	B-Falls
Unclear	O
baseline	O
Cr,	O
but	O
likely	O
had	O
some	O
post-renal	O
obstructive	O
uropathy	O
on	O
admission.	O
However	O
Cr	O
continued	O
to	O
rise	O
with	O
gentle	O
IVF.	O
She	O
developed	O
superimposed	O
contrast	O
induced	O
nephropathy.	O
#	O
Oliguric	O
___:	O
Initially	O
felt	O
to	O
be	O
post-renal	O
based	O
on	O
distended	O
bladder,	O
hydronephrosis	O
seen	O
on	O
CT	O
and	O
urine	O
lytes	O
with	O
concentrated	O
urine	O
and	O
sodium	O
avidity.	O
She	O
was	O
rehdyrated	O
with	O
2L	O
gentle	O
IVF.	O
However,	O
Cr	O
bumped	O
to	O
3.4	O
and	O
patient	O
developed	O
oliguria	O
48	O
hrs	O
after	O
admission.	O
Urinarylysis	O
was	O
bland.	O
A	O
repeat	O
renal	O
US	O
was	O
without	O
hydronephrosis,	O
with	O
patent	O
renal	O
veins.	O
This	O
acute	O
kidney	O
injury	O
was	O
felt	O
to	O
represent	O
contrast	O
induced	O
nephropathy	O
given	O
the	O
timing	O
and	O
sodium	O
avid	O
urine,	O
bland	O
sediment,	O
and	O
lack	O
of	O
response	O
to	O
IVF.	O
Her	O
home	O
aldactone	O
and	O
torsemide	O
were	O
held.	O
Her	O
creatinine	O
was	O
improved	O
to	O
2.0	O
at	O
the	O
time	O
of	O
discharge.	O
#T2	O
Spinous	O
Process	O
Fracture/Right	O
Posterior	O
5th	O
Rib	O
Fracture:	O
Trauma	O
Surgery	O
evaluated	O
patient	O
and	O
recommended	O
conservative	O
management.	O
The	O
patient	O
was	O
managed	O
initially	O
on	O
Tramadol	O
PRN	O
but	O
transitioned	O
to	O
Tylenol	O
given	O
delirium	O
and	O
urinary	O
retention.	O
#	O
Hypoxia:	O
Patient	O
was	O
initially	O
hypoxic	O
to	O
SpO2	O
less	O
than	O
95%	O
on	O
RA	O
with	O
significant	O
inspiratory	O
crackles	O
bilaterally	O
on	O
exam.	O
There	O
was	O
no	O
evidence	O
of	O
pneumonia	B-Lower_respiratory_tract_infection
on	O
CXR.	O
The	O
patient's	O
hypoxia	O
was	O
thought	O
to	O
be	O
due	O
to	O
pulmonary	O
edema	O
in	O
the	O
setting	O
of	O
receiving	O
IV	O
fluids.	O
The	O
patient	O
was	O
diuresed	O
with	O
Furosemide	O
80	O
mg	O
IV	O
with	O
good	O
urinary	O
output.	O
At	O
the	O
time	O
of	O
discharge,	O
the	O
patient	O
was	O
no	O
longer	O
hypoxic	O
on	O
room	O
air.	O
#Junctional	O
bradycardia:	O
During	O
her	O
hospitalization,	O
the	O
patient	O
was	O
found	O
to	O
be	O
bradycardic	O
with	O
HR	O
___.	O
Cardiology	O
was	O
consulted	O
and	O
it	O
was	O
felt	O
that	O
___	O
patient	O
was	O
bradycardic	O
due	O
to	O
a	O
junctional	O
escape	O
rhythm	O
likely	O
secondary	O
to	O
digoxin	O
toxicity.	O
Digoxin	O
was	O
discontinued	O
and	O
advised	O
to	O
to	O
be	O
resumed.	O
The	O
patient's	O
nodal	O
agents	O
(metoprolol	O
succinate	O
and	O
diltizem)	O
were	O
initially	O
held.	O
With	O
her	O
nodal	O
agents	O
stopped,	O
the	O
patient	O
converted	O
to	O
slow	O
atrial	O
fibrillation	O
with	O
HR	O
60-70s.	O
Her	O
metoprolol	O
was	O
restarted	O
at	O
half	O
dose	O
on	O
discharge.	O
#	O
Atrial	O
Fibrilliation:	O
CHADS	O
score	O
of	O
atleast	O
4.	O
Patient	O
initially	O
in	O
junctional	O
bradycardia	O
as	O
noted	O
above.	O
With	O
all	O
nodal	O
agents	O
held,	O
recent	O
EKG	O
___	O
at	O
rest	O
was	O
notable	O
for	O
narrow	O
complex,	O
irregularly,	O
irregular	O
with	O
rate	O
HR	O
___	O
consistent	O
with	O
slow	O
A.	O
fib.	O
The	O
patient's	O
home	O
coumadin	O
was	O
titrated	O
to	O
maintain	O
INR	O
___.	O
With	O
the	O
patient	O
back	O
in	O
Afib,	O
the	O
patient	O
was	O
started	O
on	O
a	O
lower	O
dose	O
of	O
metoprolol	O
succinate	O
25	O
mg	O
PO	O
QDaily	O
for	O
rate	O
control	O
as	O
patient	O
was	O
tachycardic	O
to	O
110s	O
with	O
activity.	O
#	O
Left	O
Lower	O
Extremity	O
Hematoma	O
and	O
Surrounding	O
Erythema	O
and	O
Warmth:	O
Patient	O
has	O
resolving	O
hematoma	O
at	O
LLE	O
which	O
continued	O
to	O
be	O
painful	O
and	O
surrounded	O
by	O
area	O
of	O
warmth	O
and	O
erythema.	O
Presentation	O
likely	O
from	O
tissue	O
damage	O
superimposed	O
on	O
known	O
bilateral	O
stasis	O
dermatitis.	O
Presentation	O
was	O
not	O
felt	O
to	O
be	O
due	O
to	O
cellulitis	O
as	O
area	O
of	O
erythema	O
and	O
warmth	O
had	O
no	O
progressively	O
increased	O
and	O
patient	O
afebrile	O
with	O
no	O
leukocytosis.	O
The	O
patient's	O
hematoma	O
and	O
area	O
of	O
erythema	O
improved	O
at	O
the	O
time	O
of	O
discharge.	O
#	O
Urinary	O
retention:	O
New	O
finding	O
per	O
PCP	O
office	O
as	O
patient	O
has	O
not	O
been	O
previously	O
documented	O
to	O
have	O
urinary	O
retention.	O
Neurogenic	O
bladder	O
from	O
her	O
diabetes	O
is	O
also	O
a	O
possibility,	O
however,	O
A1c	O
only	O
7.	O
Likely	O
drug	O
effect	O
from	O
recent	O
narcotic	O
use	O
(Tramadol)	O
for	O
pain	O
control	O
following	O
traumatic	O
fall.	B-Falls
The	O
patient's	O
foley	O
was	O
initially	O
discontinued	O
but	O
repeat	O
bladder	O
scan	O
was	O
notable	O
for	O
900	O
cc,	O
thus	O
foley	O
replaced.	O
The	O
patient	O
continued	O
to	O
have	O
urinary	O
retention	O
and	O
was	O
thought	O
to	O
be	O
related	O
to	O
her	O
underlying	O
UTI.	B-Urinary_tract_infection
At	O
discharge,	O
the	O
patient	O
passed	O
her	O
voiding	O
trial	O
and	O
the	O
foley	O
was	O
removed.	O
#	O
Complicated	O
Urinary	B-Urinary_tract_infection
Tract	B-Urinary_tract_infection
Infection	B-Urinary_tract_infection
(UTI):	O
Likely	O
Foley	O
catether-associated.	O
UA	O
and	O
urine	O
cx	O
from	O
___	O
unremarkable,	O
now	O
repeat	O
UA	O
nitrite	O
positive	O
and	O
WBC>	O
100.	O
Patient	O
otherwise	O
denies	O
any	O
symptoms,	O
but	O
patient	O
poor	O
historian.	O
Complicated	O
UTI	B-Urinary_tract_infection
given	O
recent	O
instrumentation.	O
Urine	O
cultures	O
were	O
notable	O
for	O
pansensitive	O
E.	O
coli.	O
The	O
patient	O
was	O
initially	O
managed	O
on	O
IV	O
Ceftriaxone,	O
but	O
narrowed	O
to	O
Ciprofloxacin	O
250	O
mg	O
PO	O
Q48H	O
(renally-dosed),	O
which	O
will	O
need	O
to	O
be	O
continued	O
until	O
___.	O
CHRONIC	O
ISSUES:	O
#	O
Diabetes	O
Mellitus:	O
Patient	O
admitted	O
without	O
a	O
diabetic	O
medication	O
regimen.	O
The	O
patient	O
was	O
managed	O
on	O
an	O
insulin	O
sliding	O
scale.	O
#Chronic	O
compensated	O
dCHF:	O
On	O
admission,	O
the	O
patient	O
did	O
not	O
appear	O
grossly	O
volume	O
overloaded	O
aside	O
from	O
some	O
bibasilar	O
inspiratory	O
crackles.	O
In	O
the	O
setting	O
of	O
___,	O
the	O
patient's	O
home	O
diuretics	O
were	O
held.	O
TRANSITIONAL	O
ISSUES:	O
[]	O
Code	O
Status:	O
FULL	O
[]	O
Patient	O
will	O
need	O
to	O
continue	O
Ciprofloxacin	O
250	O
mg	O
PO	O
Q24H	O
(Last	O
day	O
___.	O
[]	O
Patient	O
should	O
not	O
take	O
digoxin	O
going	O
forward	O
[]	O
Patient's	O
home	O
gabapentin	O
should	O
be	O
resumed	O
(held	O
in	O
the	O
setting	O
of	O
delirium)	O
[]	O
Patient's	O
home	O
diuretics	O
(Torsemide/Aldactone)	O
will	O
need	O
to	O
be	O
resumed	O
by	O
PCP	O
[]	O
Patient	O
started	O
on	O
lower	O
dose	O
Metprolol	O
Succinate	O
25	O
mg	O
PO	O
QDaily	O
at	O
discharge.,	O
will	O
need	O
to	O
titrate	O
back	O
to	O
home	O
dose	O
as	O
well	O
as	O
consider	O
resuming	O
Diltiazem	O
for	O
further	O
rate	O
control	O
if	O
needed	O
[]	O
Incidentilomas	O
found	O
on	O
imaging:	O
Thyroid,	O
Breast,	O
and	O
Renal	O
lesions,	O
will	O
need	O
to	O
be	O
addressed	O
by	O
PCP	O
___	O
on	O
___:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Cardizem	O
CD	O
120	O
mg	O
oral	O
daily	O
2.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
DAILY	O
3.	O
Digoxin	O
0.0625	O
mg	O
PO	O
DAILY	O
4.	O
Dorzolamide	O
2%/Timolol	O
0.5%	O
Ophth.	O
1	O
DROP	O
BOTH	O
EYES	O
BID	O
5.	O
Ferrous	O
GLUCONATE	O
324	O
mg	O
PO	O
DAILY	O
6.	O
Guaifenesin	O
___	O
mL	O
PO	O
Q4H:PRN	O
cough	O
7.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
8.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
9.	O
Gabapentin	O
300	O
mg	O
PO	O
QHS	O
10.	O
Pravastatin	O
20	O
mg	O
PO	O
QPM	O
11.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
12.	O
Prochlorperazine	O
5	O
mg	O
PO	O
Q6H:PRN	O
nasuea	O
13.	O
Senna	O
8.6	O
mg	O
PO	O
BID:PRN	O
constipation	B-Constipation
14.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
15.	O
Spironolactone	O
12.5	O
mg	O
PO	O
DAILY	O
16.	O
Torsemide	O
50	O
mg	O
PO	O
DAILY	O
17.	O
Travatan	O
Z	O
(travoprost)	O
0.004	O
%	O
ophthalmic	O
qd	O
18.	O
Warfarin	O
3	O
mg	O
PO	O
DAILY16	O
Discharge	O
Medications:	O
1.	O
Ferrous	O
GLUCONATE	O
324	O
mg	O
PO	O
DAILY	O
2.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
3.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
4.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
5.	O
Senna	O
8.6	O
mg	O
PO	O
BID:PRN	O
constipation	B-Constipation
6.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
7.	O
Travatan	O
Z	O
(travoprost)	O
0.004	O
%	O
ophthalmic	O
qd	O
8.	O
Warfarin	O
3	O
mg	O
PO	O
DAILY16	O
9.	O
Bisacodyl	O
10	O
mg	O
PR	O
QHS:PRN	O
constipation	B-Constipation
10.	O
Ciprofloxacin	O
HCl	O
250	O
mg	O
PO	O
Q24H	O
11.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
12.	O
Pravastatin	O
20	O
mg	O
PO	O
QPM	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
___	O
Diagnosis:	O
Primary:	O
Acute	O
on	O
chronic	O
kidney	O
injury	O
Fracture	O
of	O
T2	O
spinous	O
process	O
Secondary:	O
Atrial	O
fibrillation	O
Diabetes	O
mellitus	O
type	O
2	O
Chronic	O
diastolic	O
congestive	O
heart	O
failure	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_aid
-	O
requires	O
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Ms.	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
after	O
a	O
bad	O
fall.	B-Falls
You	O
fractured	O
a	O
small	O
bone	O
in	O
your	O
back	O
but	O
thankfully	O
escaped	O
any	O
other	O
serious	O
injuries.	O
You	O
were	O
noted	O
to	O
be	O
unable	O
to	O
urinate	O
and	O
had	O
sustained	O
injury	O
to	O
your	O
kidneys.	O
You	O
were	O
also	O
noted	O
to	O
be	O
in	O
an	O
abnormal	O
heart	O
rhythm	O
because	O
of	O
build	O
up	O
of	O
one	O
of	O
your	O
heart	O
medications	O
to	O
toxic	O
levels.	O
You	O
were	O
also	O
found	O
to	O
have	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
and	O
you	O
were	O
treated	O
with	O
antibiotics.	O
It's	O
been	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
the	O
___	O
-your	O
___	O
care	O
team.	O
Followup	O
Instructions:	O
___	O

